Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Annexon, Inc. (ANNX) Cash Flow Statement

Annexon, Inc. (ANNX) generated -$193.0M of operating cash flow over the twelve months to 2026-06-30, spent $185000 on capital expenditure and had free cash flow of -$193.2M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ANNXAnnexon, Inc.Follow ANNX — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
766.7M
P/E TTM
—
Dividend yield
0.0%
52-week
—
Next earnings
16 Nov, in 23 days
LineFY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-53.1-106.1-116.3-121.1-118.0-186.4-193.0
Capital expenditure0.51.76.50.20.00.1-0.2
Free cash flow-53.6-107.8-122.8-121.3-118.0-186.5-193.2
Stock-based compensation4.916.318.518.219.416.4—

USD millions · SEC XBRL

Annexon, Inc. — questions

What is Annexon, Inc.'s operating cash flow?
-$193.0M over the twelve months to 2026-06-30.
How much does Annexon, Inc. spend on capital expenditure?
$185000 over the twelve months to 2026-06-30.
What is Annexon, Inc.'s free cash flow?
-$193.2M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Annexon, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.